Cartography Biosciences

Cartography CEO Kevin Parker, Ph.D., recently sat down with the team at Alix Ventures' BIOS Builders podcast to share insight into our precision approach to #cancer, the recent news of our partnership with Gilead Sciences and where we are headed next. Listen in below! ⤵

What does the path from academia to company-creation look like? Don’t miss our CEO Kevin Parker’s #BIO2024 panel, “Moving from the Lab Bench to the Biotech C-Suite: Insights on Running a Founder-Led #Biotech,” with Heather Bowerman, Jordi Mata-Fink, Trevor Martin, Kira Poskanzer and moderator Max Bayer on Wednesday, June 5 at 4:15pm PT. Register today: bit.ly/3QjHhzr

This week, we announced our newest collaboration with Gilead Sciences, supporting our work to discover and develop therapies for patients with triple-negative #breastcancer and adenocarcinoma, emphasizing our commitment to shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets. Hear from our CEO Kevin Parker, Ph.D., as he shares his excitement around the news and where we are headed next. 

We are incredibly excited to announce today our strategic collaboration with Gilead Sciences to discover and develop therapies for patients with triple-negative #breastcancer and the most common form of non-small cell #lungcancer, adenocarcinoma. Through the collaboration, our proprietary computational and genomics platform will be utilized to discover and validate novel tumor-selective target antigens and pairs of antigens. We are focused on shaping a world in which #cancer immunotherapies are designed around and directed toward the safest and most effective targets, and we believe this collaboration brings us a step closer to creating that future. Read more in the release here: https://lnkd.in/dyi4JEBu

Cartography CEO Kevin Parker, PhD sat down with Sarah Jones of Pear VC for the latest episode of Pear Biotech Bench to Business. Check it out to hear the latest on Cartography and insights on building a discovery pipeline based on new #cancer targets: https://bit.ly/3yeJ5DN

The Cartography team recently got together for a fun-filled San Francisco Giants game! It was great to enjoy the company of our fellow Cartographers and a beautiful day at Oracle Park.   Interested in joining our team? Check out our open roles: bit.ly/3MDszAF

Planning to attend Life Science Innovation Northwest 2024 in Seattle next week? Our VP David G Kugler, PhD will be presenting a company overview on Wednesday, April 17 at 1:40pm PT.   Be sure to register and stop by to learn how Cartography is building a differentiated pipeline of antibody-based therapies designed to target tumors more precisely than existing therapeutics: bit.ly/3J9XXp4

This coming Sunday, April 7 is #WorldHealthDay. With this year’s theme being, ‘My health, my right,” it encourages those in the #biotech industry to continue advancing novel medicines to improve human health for all. At Cartography, we’re contributing to this cause by working to treat every patient with cancer.

To cater to our growing team, Cartography made the exciting move to an expanded office space – and just in time for our recent team retreat!   Highlights included engaging team discussions, collaborative work and some festive birthday celebrations. 

Check out the latest episode of BiotechTV where CEO Kevin Parker, PhD sits down with Brad Loncar to share an overview of Cartography's approach to uncovering novel #cancer targets.